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Abstract
Background: Apoptosis is a hallmark of b-cell death in both type 1 and type 2 diabetes mellitus. Understanding how
apoptosis contributes to b-cell turnover may lead to strategies to prevent progression of diabetes. A key mediator of
apoptosis, mitochondrial function, and cell survival is apoptosis inducing factor (AIF). In the present study, we investigated
the role of AIF on b-cell mass and survival using the Harlequin (Hq) mutant mice, which are hypomorphic for AIF.
Methodology/Principal Findings: Immunohistochemical evaluation of pancreata from Hq mutant mice displayed much
smaller islets compared to wild-type mice (WT). Analysis of b-cell mass in these mice revealed a greater than 4-fold
reduction in b-cell mass together with an 8-fold increase in b-cell apoptosis. Analysis of cell cycle dynamics, using BrdU
pulse as a marker for cells in S-phase, did not detect significant differences in the frequency of b-cells in S-phase. In contrast,
double staining for phosphorylated Histone H3 and insulin showed a 3-fold increase in b-cells in the G2 phase in Hq mutant
mice, but no differences in M-phase compared to WT mice. This suggests that the b-cells from Hq mutant mice are arrested
in the G2 phase and are unlikely to complete the cell cycle. b-cells from Hq mutant mice display increased sensitivity to
hydrogen peroxide-induced apoptosis, which was confirmed in human islets in which AIF was depleted by siRNA. AIF
deficiency had no effect on glucose stimulated insulin secretion, but the impaired effect of hydrogen peroxide on b-cell
function was potentiated.
Conclusions/Significance: Our results indicate that AIF is essential for maintaining b-cell mass and for oxidative stress
response. A decrease in the oxidative phosphorylation capacity may counteract the development of diabetes, despite its
deleterious effects on b-cell survival.
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Introduction
Apoptosis of the insulin producing b-cells and the decline in b-
cell mass is a major mechanism of the progression of diabetes [1].
In addition, the rapid loss of b-cell function and the relative
discrepancy between insulin demand and insulin secretion worsen
the ability of the organism to maintain normoglycemia.
Important metabolites that regulate insulin secretion are
generated in the mitochondria [2,3]. The b-cell mitochondria
are key regulators of glucose stimulated insulin secretion, and
several mitochondrial pathways are disabled in type 2 diabetes
(T2DM), e.g. the glucose induced hyperpolarization of the
mitochondrial membrane and the raise in the ATP/ADP ratio
at high glucose. Diabetic islets also have increased UCP-2
expression, which uncouples mitochondrial oxidative phosphory-
lation, such that energy is wasted through heat, and cellular ATP
synthesis is decreased, probably through an increased formation of
reactive oxygen species (ROS) [4].
Besides regulating factors of insulin secretion, mitochondria play
a prominent role in apoptosis. In b-cells, elevated free fatty acids
and production of ROS have been shown to induce apoptosis
through the release of cytochrome c from the inner mitochondrial
membrane to the cytosol, which triggers caspase activation [5,6].
Mitochondria are the principal source of ROS in the b-cell [7],
which accumulates when the respiratory chain function is
defective. The low expression of an antioxidant enzyme defense
system makes the b-cells particularly susceptible to an oxidative
insult [8].
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membrane protein, which translocates to the cytoplasm and
nucleus during apoptosis [9], where it binds to DNA triggering
DNA fragmentation and nuclear condensation [9,10]. In contrast
to cytochrome c, AIF induces apoptosis in a caspase-independent
fashion [11]. AIF is essential for mammalian development,
knocking out AIF in the mouse is lethal before birth [12].
Therefore, the role of AIF as a death executor or as an oxidative
stress scavenger is controversial. Evidence that AIF serves as free
radical scavenger to prevent apoptosis came from studies on the
Harlequin (Hq) mutant mouse. These mice have an 80% reduction
in AIF protein due to a proviral insertion in the first intron of the
AIF gene. They exhibit a reduced oxidative phosphorylation
(OxPHOS) in the retina and in the brain, which entails increased
oxidative stress and neuronal cell death through unscheduled cell
cycle reentry [13].
Defects in OxPHOS and mitochondrial energy metabolism
have been implicated in human diseases, including insulin
resistance [14,15] and diabetes mellitus [16], neurodegenerative
disorders such as Alzheimer’s disease, Parkinson’s disease, as well
as aging [17,18]. Given the different roles of AIF in maintaining a
functional respiratory chain, protecting cells from oxidative stress,
but also contributing to stress- induced cell-death and that
important mitochondrial pathways control b-cell pathophysiology,
we asked the question what role does AIF play in the regulation of
b-cell survival, mass and insulin secretion?
Materials and Methods
Animal breeding and genotyping
Harlequin (Hq) arose on a CF1 outbred stock and was
transferred to a BGCBACa-A
w-J/A (B6CBA) background. The
Hq mice were obtained from Jackson Laboratory (Bar Harbor,
ME). For controls, WT littermates which do not have the Hq
mutation (+/Y) were used. Animals were housed at 22uC with a
12-h light-dark cycle (lights on at 07:00) and allowed free access to
water and chow according to the protocol approved by the UCLA
Chancellor’s Animal Research Committee in agreement to NIH
animal care guidelines.
Islet isolation and culture
Human islets from six different donors were obtained from the
Islet cell resource center (ICR-ABCC) or the European Consor-
tium for Islet Transplantation (ECIT). Mouse islets were isolated
by bile duct perfusion and collagenase digestion as described
before [5]. The islets were cultured in suspension culture dishes.
Human islets were cultured in CMRL 1066 medium containing
5.5 mM glucose and mouse islets in RPMI 1640 medium
containing 11.1 mM glucose, both supplemented with 100 U/ml
penicillin, 100 mg/ml streptomycin and 10% FCS (Invitrogen
Ltd., Carlsbad, CA), hereafter referred to as culture medium. Islets
were pre-cultured for 48 h after the isolation before the
experiment, in some experiments, islets were transfected with
siRNA and/or treated with 50 mMH 2O2 (Sigma) for 2 h.
b-cell mass analysis and immunohistochemistry
At the age of 2 and 9 weeks of age, mice were sacrificed and
pancreata dissected, weighed and fixed in formalin followed by
paraffin embedding, orienting pancreata such that sections were
cut along the head-tail axis. Sections for b-cell mass were at least
50 microns apart. Five representative sections from each pancreas
(spanning the width of the pancreas) were used in the analysis of b-
cell mass. Pancreatic and islet sections were deparaffinized in
toluene, rehydrated in grades of alcohol and washed in H2O.
Slides were exposed to antigen-retrieval using antigen unmasking
buffer according to the manufacturer’s instructions (Vector
Laboratories, Inc. Burlingame, CA). After antigen unmasking,
the sections were cooled to room temperature, permabilized in
0.4% Triton X-100/TBS for 30 min, and blocked with 0.2%
Tween 20/3% IgG-free BSA/2% Triton X-100/TBS. Primary
antibodies were diluted at the following dilutions: guinea pig anti-
insulin 1:50 (Dako, Carpinteria, CA), mouse anti-glucagon 1:1000
(Sigma-Aldrich, St. Louis, MO), rabbit anti-phosphohistone H3
1:200 (Upstate, Charlottesville, VA) followed by detection with
donkey-and goat-derived secondary antibodies conjugated to
FITC and Cy3 (Jackson ImmunoResearch Laboratories, West
Grove, PA). A montage of the whole pancreatic section was
created using OpenlabTM and ImageJ software (Improvisison,
MA) on a Leica DM6000. The relative area of b-cells (green
fluorescence) was determined by quantification of the cross-
sectional b-cell area divided by the cross-sectional area of total
tissue. b-cell mass per pancreas was estimated as the product of the
relative cross-sectional area of b-cells per total tissue and the
weight of the pancreas.
To obtain sections from isolated islets, islets were washed with
PBS, fixed in Bouin’s solution for 15 min. and resuspended in 2%
melted agarose in PBS, followed by short centrifugation and
paraffin embedding. 4 mM islet sections were cut and re-hydrated.
For detection of b-cell apoptosis, sections were incubated with
20 mg/ml proteinase K (Roche Diagnostics, Indianapolis, IN) for
12 min at 37uC and blocked with 0.2% Tween 20/3% IgG-free
BSA/2% Triton X-100/TBS. Apoptosis was analyzed by the
terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling (TUNEL) technique according to the manufacturer’s
instructions (In Situ Cell Death Detection Kit, TMR red; Roche).
Then, sections were double-stained for insulin as described above.
Intra-peritoneal glucose tolerance test (IPGTT)
Mice were fasted for 16 h, baseline blood glucose levels were
measured in tail-vein blood from mice using a Glucometer
(Freestyle, TheraSense Inc, Alameda, CA). Glucose (2 mg/g body
weight) was injected intraperitoneally and blood glucose was
measured 15, 30, 60, and 120 min after injection.
b-cell proliferation
5-bromo-2-deoxyuridine (BrdU) incorporation: BrdU was inject-
ed intraperitoneally (0.025 mg/g body weight) 2 h before harvest-
ing the pancreata. Pancreata were isolated and processed for
histology as described above. Mouse anti-BrdU antibody/nuclease
solution (Amersham/Pharmacia) was applied for 1 h at RT and
double staining for insulin was performed as described above.
RNA extraction and quantitative RT-PCR analysis
Isolated islets were washed in cold PBS and homogenized in Tri
Reagent (Molecular Research Center Inc.), and the total RNA was
preparedaccordingtothemanufacturer’smethods.Forquantitative
analysis, we used the LightCycler Quantitative PCR System
(Roche) with a commercial kit (LightCycler FastStart DNA Master
plus SYBR Green I, Roche). Primers used were: 59-AGTGGAA-
GACTGGCTGGAGA-39 and 59-TCACTCTCCGAACGGA-
TACC-39 (mouse AIF); 59-GTTGGCCAGGCTGGTGTCCAG-
39 and 59-CTGTGATGAGCTGCTCAGGGTGG-39 (tubulin).
RNA interference
A knock down of AIF mRNA and protein levels was carried out
using the small interfering RNA (siRNA) technique. The siRNA
duplex was designed against the following target sequence:
AIF in b-Cells
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The negative scramble siRNA #1 (Ambion, Austin, TX) was
used as control. Transfection of cultured human islets with siAIF
and control siRNA was performed by Lipofectamine2000
(Invitrogen) according to the manufacturer’s instructions. Cell
lysates were collected 72 h after transfection.
Western blot analysis
Islets were washed in PBS and lysed for 40 min on ice in 40 ml
lysis buffer containing 20 mM Tris acetate, 0.27 M sucrose, 1 mM
EDTA, 1 mM EGTA, 50 mM NaF, 1% Triton X-100, 5 mM
sodium pyrophosphate and 10 mM b-glycerophosphate. Prior to
use, the lysis buffer was supplemented with Protease- and
Phosphatase-inhibitors (Pierce, Rockford, IL). Equal amounts of
protein of each treatment group were run on NuPAGE 4–12%
Bis-Tris gels. After transfer onto PVDF filters, nonspecific binding
sites were blocked for 1 h using 5% nonfat dry milk and 0.05%
Tween 20 in Tris-buffered saline and incubated with rabbit anti-
AIF 1:1000 (Chemicon International, Temecula, CA) followed by
horseradish-peroxidase-linked anti-rabbit IgG peroxidase. The
emitted light was captured on X-ray film after adding Immobilon
Western chemiluminescent HRP substrate (Millipore, Billerica,
MA). To verify that equal amounts of protein were loaded,
membranes were stripped and re-probed with rabbit anti-b-actin
(Cell signaling, Beverly, MA).
Glucose stimulated insulin secretion (GSIS)
After treatment, islets were washed and pre-incubated (30 min)
in Kreb’s Ringer bicarbonate buffer (KRB) containing 2.8 mM
glucose and 0.5% BSA. KRB was then replaced by KRB 2.8 mM
glucose for 1 h (basal), followed by an additional 1 h in KRB
16.7 mM glucose (stimulated). Islets were extracted with 0.18 N
HCl in 70% ethanol for determination of insulin content. Islet
insulin was determined using mouse insulin ELISA (ALPCO,
Salem, NH).
Statistical analysis
All data were expressed as means+/2SE. The statistical
significance of differences was measured by Student’s t test.
Results
AIF depletion decreases b-cell mass
To understand if AIF plays a role in the regulation of survival in
b-cells, we analyzed both mRNA and protein expression of AIF in
isolated mouse and human pancreatic islets. RT-PCR analysis
showed the mRNA transcript of AIF in both human and mouse
islets. Western blot analysis confirmed the expression of AIF
protein in isolated human and mouse islets (Fig. 1A). To elucidate
if AIF played a role in the establishment of the endocrine pancreas,
we compared the islet cellular composition of WT mice and Hq
mutant mice, a hypomorphic AIF mouse model in which the
expression of AIF is reduced to 10–20% of wild type littermates.
This depletion of AIF was confirmed in isolated islets by RT-PCR
and Western Blot analysis (Fig. 1A). Immunohistochemical
evaluation of pancreata revealed normal islet morphology in the
Hq mutant mice (Fig. 1B). Islet b-cell mass was 2.7-fold reduced in
2-week (p,0.001) and 4.6-fold in 9-week-old (p,0.01) Hq mutant
mice, respectively compared to their WT littermates (Fig. 1C).
The average weight of a Hq pancreas was 53% of WT littermate
pancreas at the age of 2 weeks and 60% at the age of 9 weeks
(p,0.01). Normalization of the b-cell mass to whole body mass still
resulted in a 39% and 68% decrease in the Hq mice at the age of 2
and 9 weeks, respectively. (Fig. 1D).
Possible reasons for the decreased b-cell mass could be
increased b-cell apoptosis and/or reduced proliferation. Previous
studies show that neurons from Hq mutant mice display an
increased propensity to re-enter the cell cycle, which results in
aberrant apoptotic destruction of the neurons [13]. To determine
if cell cycle dynamics were misregulated in the Hq b-cells, we
analyzed the incorporation/expression of cell cycle markers of b-
cells in Hq mutant mice. A BrdU pulse was administered to 4 week
old Hq and WT littermates 2 h before sacrifice to mark cells that
were currently in S-phase. BrdU
+insulin
+ double-positive cells
were counted as b-cells in S phase. Immunohistochemistry for
phosphorylated Histone H3 (pHH3) staining allows one to
discriminate cells in G2 or M phases of cell cycle [19,20].
pHH3+insulin+ (with punctuated pattern) cells were counted as b-
cells at G2 phase. pHH3+insulin+ (with a homogeneously
condensed pattern of strong nuclear expression) cells were counted
as b-cells at M phase (Fig. 1F). Analysis of BrdU incorporation did
not reveal any significant difference in proliferating cells between
WT and Hq mutant mice (Fig. 1E). However, pHH3 staining
showed a 3-fold increase in b-cells in the G2 phase in Hq mutant
mice but no differences in M-phase (Fig. 1E, p,0.05), an example
of such punctuated staining pattern in the Hq mice is shown in
Fig. 1F. This suggests that b-cells from Hq mutant mice either stop
or prolong the G2 phase and some do not further re-enter the cell
cycle. Previous studies show that such cells are highly prone to
apoptosis [21,22]. To test this possibility, we analyzed b-cell
apoptosis in pancreatic sections from WT and Hq mutant mice at
different ages. b-cell apoptosis in Hq mutant mice was increased at
all ages compared to WT (Neonates P0: 0.4% in Hq mutant mice
versus 0.2% in WT. No apoptosis was observed in the islets from
WT mice at all further ages analyzed but the number of apoptotic
b-cell in the Hq mutant mice were at P7: 0.3%, P14: 0.1%, 4-
weeks-old: 0.2% and 9-weeks-old: 0.2%.)
AIF depletion in mice leads to increased b-cell apoptosis
Based on our in vivo results, we studied b-cell apoptosis from
isolated islets in order to further investigate the nature of the b-cell
loss in Hq mutant mice. Neurons [13] as well as cardiomycytes
[23] from Hq mutant mice are highly susceptible to cell death
induced by oxidative stress. Isolated mouse islets from mutant and
WT animals were treated with 50 mMH 2O2 for 2 h and b-cell
apoptosis was analyzed by double staining for TUNEL and
Figure 1. Decreased b-cell mass in Hq mutant mice. (A). Representative Western blots (panel 1,3) and PCR analyzes (panel 2,4) of AIF expression
in isolated mouse (panel 1,2) and human (panel 3,4) islets. Actin was used as loading control/ house keeping gene. Western blots/ PCRs are
representatives of three independent experiments from three mice or from 3 organ donors, respectively. (B) Histological analysis by insulin staining
in green and glucagon staining in red show a normal islet cellular composition and smaller islets in 2-week-old Hq mutant mice. (C,D) Analysis of b-
cell mass (C) or b-cell mass divided by body weight (D) of WT and Hq mutant mice at 2 and 9 weeks of age. Values are representative of 5 slides
spanning the whole pancreas of each mouse and 4 mice for each group at each age (magnification x125). (E) Cell cycle characteristics of b-cells from
WT mice and Hq mutant mice as measured by BrdU and pHH3 staining. BrdU
+insulin
+ cells are counted as b-cells at S phase (see example in F, upper
panel). pHH3
+ (with punctuated pattern) insulin+ cells are counted as b-cells at G2 phase (see example in F, Hq mice lower right panel). pHH3
+ (with
strong nuclear expression) insulin+ cells were counted as b-cells at M phase (see example in F, WT mice lower left panel). Data are shown as
mean6SE. *P,0.05 in Hq mutant mice vs. WT mice.
doi:10.1371/journal.pone.0004394.g001
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apoptosis in the Hq mutant mice islets was 8-fold increased in
the untreated islets (*p,0.05). When islets were exposed to H2O2,
there was a 16.5-fold increase in b-cell apoptosis in the WT mice
(**p,0,05), and a 14-fold increase in the Hq mutant mice islets
(p,0.05). When compared to the WT mice, there was a 6.8-fold
increase in the Hq mutant mice islets (p,0.05), when islets were
exposed to H2O2 (Fig. 2A&B). Because apoptosis results in
decreased b-cell mass, we hypothesized that Hq animals would be
hyperglycemic. Contrary to our predictions, Hq mutant mice
showed significantly lower fasting blood glucose levels as well as
improved glucose tolerance during an ipGTT (Fig. 2C). Our data
confirm previously published data that AIF depletion in the liver
and/or skeletal muscle leads to increased insulin sensitivity [15].
Because Hq mice are global hypomorphs, we can only assume that
minimal insulin secretion from the reduced b-cell mass is sufficient
to maintain glucose homeostasis in insulin hyper-sensitive mice.
This indicates that hepatic and muscular defects in the oxidative
phosphorylation may counteract the development of diabetes,
despite its deleterious effects on b-cell survival.
AIF depletion leads to increased b-cell apoptosis in
human islets without affecting insulin secretion
To investigate the significance of AIF and oxidative stress in
human islets, AIF was knocked down by small interfering RNAs
(siRNA). Western blot analysis of AIF expression shows 76%
downregulation of AIF protein expression in human islets exposed
for 3 days to siRNA directed to AIF (siAIF) versus scrambled
control (siScr, Fig. 3A). In line with our observations in islets from
Hq mutant mice, exposure of isolated human islets to siAIF
resulted in a 8.8-fold increase in b-cell apoptosis (p,0,05),
analyzed by double staining for TUNEL and insulin (Fig. 3B).
After exposure to the siRNAs, isolated human islets were treated
with 50 mMH 2O2 for 2 h. This resulted in a 26-fold increase in b-
cell apoptosis in the siScr islets and a 6.5-fold increase in the siAIF
treated islets (Fig. 3B, p,0.05). Furthermore, H2O2-induced b-cell
apoptosis was 2-fold higher in the AIF depleted islets compared to
siScr control (p,0.05).
To assess the effect of AIF depletion on insulin secretion, we
have performed a glucose stimulated insulin secretion assay (GSIS)
in siAIF and siScr transfected human islets. Basal and stimulated
insulin secretion (Fig. 3C) as well as the stimulatory index (Fig. 3D)
was not significantly changed in response to AIF depletion.
Despite its deleterious role in inducing b-cell apoptosis, AIF
depletion did not impair b-cell function, neither basal nor glucose
stimulated insulin secretion. Then we compared response to
H2O2. As expected, H2O2 decreased glucose stimulated insulin
secretion in control as well as in siAIF treated islets. Stimulatory
index was decreased by 23% by H2O2 in siScr islets and by 40% in
siAIF islets (p,0.05), assuming that AIF plays a role to protect the
islets from oxidative stress, but is not involved in insulin secretion
itself.
Discussion
Recent work in Hq mutant mice, which have an 80% decrease
in AIF expression, suggests that AIF depletion results in increased
neuronal cell death [13]. Under physiologic conditions, AIF acts as
a free radical scavenger in the mitochondrial respiratory chain to
prevent apoptosis. Considering the high correlation of mitochon-
drial dysfunction and oxidative stress with T2DM, we hypothe-
sized that AIF may play an important role in the regulation of b-
cell mass and survival.
In the present study, we report that AIF depletion results in a 3-
fold decrease in b-cell mass at 2-weeks of age which was further
decreased with age. This was due to the missregulation of cell cycle
control. Although there was no difference in proliferating b-cells in
the Harlequin mice, 3-fold more b-cells in the Hq mice retained in
G2 phase of the cell cycle. In accordance to previous studies we
found that Hq b-cells are highly prone to apoptosis [21,22].
A proposed mechanism for the induction of apoptosis could be
oxidative stress, which is associated with abnormal cell cycle
checkpoint function. Under normal circumstances the cell cycle
proceeds without interruptions. However, if cycling cells are
damaged by agents which induce oxidative stress, a G2 check
point response is triggered and cells pause and repair the damage
[24]. In the case of a severe damage, cells may alternatively
undergo apoptosis. Given the role of AIF in mitochondrial
respiration as a hydrogen peroxide scavenger, loss of AIF could
result in an accumulation of ROS, which would then generate a
misregulation of b-cell cycle and apoptosis. This is further
supported by the finding, that b-cells from both AIF-deficient
mice (Hq mutant mice) and human islets (AIF-siRNA-treated)
displayed increased sensitive to cell death induced by hydrogen
peroxide. b-cells are in general very sensitive to oxidative stress, in
particular with hydrogen peroxide, due to their low expression of a
peroxide scavenging system [7].
Given the role of b-cell mitochondria as key regulators of
glucose stimulated insulin secretion, we hypothesized that Hq mice
show an impaired glucose tolerance. Surprisingly, and in
accordance to a recent study, AIF deficiency in Hq mutant mice
did not impair glucose tolerance. Hq mice were rather hypogly-
cemic compared to wt. This could be due to impaired glucose
sensing as a result of selective neuron loss reported in Hq mutant
mice, but is more likely to be a result of improved insulin sensitivity
[15]. Many studies have linked changes in mitochondrial oxidative
phosphorylation to the development of insulin resistance and
diabetes [14,16,25]: Importantly, a recent study in tissue specific
muscle- and liver AIF knockout mice and Hq mice with a global
AIF deficiency shows that a primary OxPhos defect alone does not
cause diabetes, but rather increases insulin sensitivity and reduces
fat mass [15]. In line with our results, this study found that Hq
mice displayed improved glucose tolerance associated with
reduced fasting and glucose-induced insulin secretion, possibly
due to the improved insulin sensitivity. This explains, why Hq mice
still maintain normoglycemia, despite their loss of b-cell mass.
Interestingly, in the absence of oxidative stress, AIF depleted
human islets did not show any changes in insulin secretion. When
compared to WT islets, Hq islets showed a similar response to
glucose, confirming the hypothesis that AIF does not directly act
on insulin secretion. Nevertheless, when islets were exposed to
H2O2, insulin secretion was further impaired in the AIF depleted
islets, assuming that AIF plays a role in protecting the islets from
oxidative stress, but is not involved in insulin secretion itself.
Figure 2. AIF depletion in mice leads to increased b-cell apoptosis. (A, B) Triple staining for TUNEL in red, insulin in green and 49,6-
diamidino-2-phenylindole (DAPI) in blue was performed on fixed, paraffin-embedded sections from isolated islets from 9-week old mice treated for
2 h with or without 50 mMH 2O2. (B) Results are expressed as percentage of TUNEL-positive b-cells6SE. The mean number of b-cells counted was 700
for each treatment condition. (C) Glucose tolerance test with 2 mg/g BW glucose: Fasting and glucose stimulated plasma glucose levels are
significantly lower in 12–16 week old Hq mutant mice (n=9) compared to age-matched WT mice. Data are shown as mean + SE. *p,0.05 in Hq
mutant mice vs. wt mice. **p,0.05 in H2O2 treated vs. untreated control.
doi:10.1371/journal.pone.0004394.g002
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anaerobic glucose metabolism and increase in fuel utilization [15].
It is important to note; that the Hq mice, despite their OxPhos
deficiency, had no indication of elevated ROS levels [26].
However, our finding that AIF is necessary for maintaining b-
cell mass is in favor of a critical role of ROS signaling and
oxidative stress in the b-cells and supports the role of AIF as a free
radical scavenger in the mitochondrial respiratory chain to prevent
apoptosis.
Our data provide new insights into a protective effect of AIF on
b-cell turnover. Loss of AIF could therefore be one of the
mechanisms of b-cell apoptosis.
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Figure 3. AIF depletion leads to increased b-cell apoptosis in human islets without affecting insulin secretion. (A) Isolated human
pancreatic islets were exposed to siRNA to AIF (siAIF) or scrambled control siRNA (siScr) for 3 days. The knockdown efficiency was determined by
Western blot analysis. Actin was used as a loading control on the same membrane after stripping. This Western blot is representative of three
independent experiments from three different organ donors. The density of expression levels were quantified after scanning and normalised to actin
levels. (B–D) 3 days after transfection, islets were exposed to 50 mMH 2O2 for 2 h. (B) Islet sections were prepared for analysis of b-cell apoptosis by
the TUNEL assay. Islets were double-stained for insulin in green and counterstained for DAPI in blue. Results are means6SE of the percentage of
TUNEL-positive b-cells. The mean number of b-cells counted was 3400 for each treatment condition. (C,D) GSIS: after the H2O2 treatment, islets were
washed and basal and stimulated insulin secretion analyzed during successive 1-h incubations at 2.8 mM (basal) and 16.7 mM (stimulated) glucose.
Data are normalized to insulin content. (D) Stimulatory index denotes the ratio between stimulated and basal values of insulin secretion. (B–D) All
assays were performed in triplicate or quadruplicate in three independent experiments from 3 different organ donors, respectively. *p,0.05 to siScr
control, **p,0.05 in H2O2 treated vs. untreated control.
doi:10.1371/journal.pone.0004394.g003
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